What mixed‑salt amphetamine stimulant medications are available?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 24, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Mixed Amphetamine Salt Medications

The primary mixed amphetamine salt medications available are Adderall (immediate-release mixed amphetamine salts), Adderall XR (extended-release mixed amphetamine salts), and Mydayis/SHP465 (triple-bead extended-release mixed amphetamine salts).

Available Formulations

Immediate-Release Mixed Amphetamine Salts (MAS IR)

  • Brand name: Adderall
  • Composition: Contains a 3:1 ratio of dextroamphetamine to levoamphetamine 1
  • Components: Dextroamphetamine sulfate, dextro- and levoamphetamine sulfate, dextroamphetamine aspartate, levoamphetamine aspartate, and dextroamphetamine saccharate 2
  • Duration: Requires twice-daily dosing

Extended-Release Mixed Amphetamine Salts (MAS XR)

  • Brand name: Adderall XR
  • Mechanism: Dual-release system with immediate-release pellets that deliver half the dose upon ingestion and delayed-release pellets that release approximately 4 hours later 1
  • Duration: Provides 12-hour coverage with onset within 1.5 hours 1
  • Composition: Same 3:1 dextroamphetamine to levoamphetamine ratio as immediate-release formulation 1

Triple-Bead Mixed Amphetamine Salts (SHP465)

  • Brand name: Mydayis
  • Duration: Enhanced extended-release formulation designed for up to 16 hours of action 3
  • Dosing: Available in 12.5-25 mg doses 4
  • Evidence: Demonstrated efficacy in both children/adolescents 4 and adults 3, with significant improvements in ADHD symptoms extending into late afternoon and evening hours 3

Clinical Context

Mixed amphetamine salts are FDA-approved stimulant medications for ADHD treatment. While guidelines recommend stimulants as first-line therapy 5, the specific choice between methylphenidate-based and amphetamine-based formulations should consider individual patient factors including symptom severity, duration of coverage needed, and comorbidities 5.

Important caveat: Although amphetamine has FDA approval for use in children younger than 6 years, this authorization predates current stringent approval criteria, and evidence for dextroamphetamine in preschool-aged children is insufficient to recommend it as initial treatment 6. Methylphenidate remains the recommended first-line medication for preschool-aged children when pharmacotherapy is indicated 6.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.